initial side effects of semaglutide for diabetes and obesity treatment Ozempic (Semaglutide): GLP-1 receptor agonist

Vitamin B Deficiency: Addresses deficiencies in B1, B6, and B12, which can lead to symptoms like fatigue, anemia, and nerve damage

The drug has been available on the NHS since 2018 to those with treat diabetes and has just been approved as a weight-loss aid, in what experts say is a pivotal moment in the fight against obesity

The body sees these medications as being similar to a natural substance GLP-1 that influences glucose control through a few different ways, one of which being slowed gastric emptying

The Flex Score is a weekly updated rating that combines nutrition, activity, exercise, and metabolic breath data to provide a measure of how well the body switches between burning carbs and fat for energy